24% in primary kidney outcome 29% in cardiovascular death 20% in all-cause mortality Read the full study here: nejm.org/doi/full/10.10 #MedTwitter #KidneyHealth #DiabetesResearch #HealthcareInnovation New @NEJM study reveals #Semaglutide (#Ozempic) significantly reduces risks of major kidney events, cardiovascular outcomes, and mortality in patients with type 2 #diabetes and chronic kidney disease
Ready to Optimize Your Power Solution
The Association Between Carnitine Levels and Neuropsychiatric Disorders Depression One of the most compelling areas of research is the link between carnitine levels and major depressive disorder (MDD)
Early diagnosis and close collaboration with a veterinarian are essential to address underlying health issues and guide appropriate medical management
If you suddenly stop taking sertraline, you may experience withdrawal symptoms such as nausea, sweating, depression, mood changes, frenzied or abnormally excited mood, irritability, anxiety, confusion, dizziness, headache, tiredness, seizures, ringing in the ears, numbness or tingling in the arms, legs, hands, or feet, difficulty falling asleep or staying asleep
